Literature DB >> 17632226

Olanzapine-induced chylomicronemia presenting as acute pancreatitis.

Alexander Martin Rossor, Nicola Leech, R Dermot G Neely.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17632226     DOI: 10.1097/01.jcp.0000264988.55603.bb

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  5 in total

1.  Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review.

Authors:  Haiyun Xu; Xiaoyin Zhuang
Journal:  Neuropsychiatr Dis Treat       Date:  2019-07-22       Impact factor: 2.570

2.  Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.

Authors:  Dianna Wolfe; Salmaan Kanji; Fatemeh Yazdi; Pauline Barbeau; Danielle Rice; Andrew Beck; Claire Butler; Leila Esmaeilisaraji; Becky Skidmore; David Moher; Brian Hutton
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240

3.  Olanzapine-induced acute necrotising pancreatitis leading to recurrent multiple organ dysfunction syndrome.

Authors:  Stelios Naxakis; Meghan Wafer; Ruth Collins
Journal:  Gen Psychiatr       Date:  2022-03-03

Review 4.  Analysis of the clinical characteristics of olanzapine-induced acute pancreatitis.

Authors:  Yang He; Weijin Fang; Zuojun Li; Linli Sun; Yulu Zhou; Cuifang Wu; Wei Sun; Chunjiang Wang
Journal:  Ther Adv Psychopharmacol       Date:  2022-04-29

5.  Antidopaminergic drugs and acute pancreatitis: a population-based study.

Authors:  Robert Bodén; Tomas S Bexelius; Fredrik Mattsson; Jesper Lagergren; Mats Lindblad; Rickard Ljung
Journal:  BMJ Open       Date:  2012-05-11       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.